Literature DB >> 3323169

A review of the in-vitro activity of roxithromycin against genital pathogens.

G L Ridgway1.   

Abstract

The in-vitro activity of roxithromycin against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum, Treponema pallidum, Gardnerella vaginalis and Haemophilus ducreyi is reviewed. Roxithromycin demonstrated equivalent activity to erythromycin against N. gonorrhoeae, C. trachomatis, M. hominis, U. urealyticum, G. vaginalis and H. ducreyi. In a rabbit model for syphilis, potentially useful activity against T. pallidum has been demonstrated.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3323169     DOI： 10.1093/jac/20.suppl_b.7

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  6 in total

1.  Roxithromycin treatment of mouse chlamydial salpingitis and protective effect on fertility.

Authors:  J Zana; M Muffat-Joly; D Thomas; J Orfila; J Salat-Baroux; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Rapid determination of MICs of 15 antichlamydial agents by using an enzyme immunoassay (Chlamydiazyme).

Authors:  A Bianchi; C Scieux; C M Salmeron; I Casin; Y Perol
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

3.  Evaluation of OPC-17116 against important pathogens that cause respiratory tract infections.

Authors:  H Wakebe; T Imada; H Yoneda; F Mukai; K Ohguro; K Ohmori; H Tamaoka; Y Yabuuchi
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

4.  Mechanisms of macrolide resistance in Ureaplasma urealyticum: a study on collection and clinical strains.

Authors:  G Palù; S Valisena; M F Barile; G A Meloni
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

Review 5.  Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  R A Young; J P Gonzalez; E M Sorkin
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

Review 6.  On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections.

Authors:  R Matthew Chico; Berkin B Hack; Melanie J Newport; Enesia Ngulube; Daniel Chandramohan
Journal:  Expert Rev Anti Infect Ther       Date:  2013-11-06       Impact factor: 5.091
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.